Mednet Logo
HomePrimary CareQuestion

What is your approach in a patient who develops interstitial lung disease while on anti-TNF therapy?

1 Answers
Mednet Member
Mednet Member
Rheumatology · Dartmouth-Hitchcock Medical Center

I would stop the TNF antagonist and never use this class of drugs again in the patient. In fact, I generally stay away from TNF antagonists in RA patients with any sign of pre-existing lung disease. The experience of Nakashita et al., PMID 25125479 is highly informative and parallels my experience, ...

Register or Sign In to see full answer

What is your approach in a patient who develops interstitial lung disease while on anti-TNF therapy? | Mednet